Health Care Costs Associated With Treatment Modification in Type 2 Diabetes Mellitus Patients Taking Oral Anti-diabetic Drugs
More like this
- Hemoglobin A1c Outcomes and Health Care Resource Use In Type 2 Diabetes Mellitus Patients Treated With Combination Oral Antidiabetic Drugs Through Step Therapy And Loose-Dose and Fixed-Dose Combinations
- The Cost-Effectiveness of Omega-3 Supplements For Prevention of Secondary Coronary Events
- Can Amylin Analogue Lead To Better Diabetes Control?
- Oral diabetes agent use is up, but insulin use falls
- A Comparison of Diabetes Patients' Self-Reported Health Status With Hemoglobin A1c Test Results In 11 California Health Plans